HTEC ETF

$35.08
Screen 3,400+ ETFsFind similar ETFs with lower fees
Leveraged fundWeights reflect notional exposure via swaps/derivatives and do not sum to 100%.
Net exposure
134.6%
Gross exposure
134.6%
Long
134.6%
Cash & collateral
0.0%
As of Apr 30, 2026
Showing 10 of 60 holdings(as of Apr 30, 2026)
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1AXGNAxoGen, Inc.3.04%--••••••••••••••••••••••
2ARWRARROWHEAD PHARMACEUTICALS, INC.2.63%--••••••••••••••••••••••
3GHGUARDANT HEALTH, INC.2.57%--••••••••••••••••••••••
4NVCRNOVOCURE LIMITED2.33%--••••••••••••••••••••••
5GRALGrail Inc2.25%--••••••••••••••••••••••
6LIVNLIVN2.21%--••••••••••••••••••••••
7VCYTVeracyte Inc2.20%--••••••••••••••••••••••
8GKOSGLAUKOS CORPORATION2.17%--••••••••••••••••••••••
9ILMNILLUMINA, INC.2.13%--••••••••••••••••••••••
10NTRANATERA, INC.2.10%--••••••••••••••••••••••
Want to see all 60 holdings?View All HoldingsPRO

HTEC ETF Top Holdings

HTEC holdings top 10 positions. The top 10 holdings account for 23.6% of the fund, led by AxoGen, Inc. at 3.0%, ARROWHEAD PHARMACEUTICALS, INC. at 2.6%, GUARDANT HEALTH, INC. at 2.6%.

HTEC portfolio concentration is well-diversified, with the top 10 representing 23.6% of total assets. The largest sector exposure is Unknown at 134.6%.

HTEC sector allocation provides a detailed breakdown. HTEC overlap tool shows how holdings compare to other funds in your portfolio.

Showing 10 of 60 holdingsNet exposure: 134.6%
#TickerNameIndustryWeightAllocation
1AXGNAxoGen, Inc.Unknown3.04%
2ARWRARROWHEAD PHARMACEUTICALS, INC.Unknown2.63%
3GHGUARDANT HEALTH, INC.Unknown2.57%
4NVCRNOVOCURE LIMITEDUnknown2.33%
5GRALGrail IncUnknown2.25%
6LIVNLIVNUnknown2.21%
7VCYTVeracyte IncUnknown2.20%
8GKOSGLAUKOS CORPORATIONUnknown2.17%
9ILMNILLUMINA, INC.Unknown2.13%
10NTRANATERA, INC.Unknown2.10%
Want to see all 60 holdings?

Holdings Distribution

Loading chart...